The kinase DOUBLETIME is a master regulator of the Drosophila circadian clock, yet the mechanisms regulating its activity remain unclear. A proteomic analysis of DOUBLETIME interactors led to the identification of an unstudied protein designated CG17282. RNAi-mediated knockdown of CG17282 produced behavioral arrhythmicity and long periods and high levels of hypophosphorylated nuclear PERIOD and phosphorylated DOUBLETIME. Overexpression of DOUBLETIME in flies suppresses these phenotypes and overexpression of CG17282 in S2 cells enhances DOUBLETIME-dependent PERIOD degradation, indicating that CG17282 stimulates DOUBLETIME's circadian function. In photoreceptors, CG17282 accumulates rhythmically in PERIODand DOUBLETIME-dependent cytosolic foci. Finally, structural analyses demonstrated CG17282 is a noncanonical FK506-binding protein with an inactive peptide prolyl-isomerase domain that binds DOUBLETIME and tetratricopeptide repeats that may promote assembly of larger protein complexes. We have named CG17282 BRIDE OF DOUBLETIME and established it as a mediator of DOUBLETIME's effects on PERIOD, most likely in cytosolic foci that regulate PERIOD nuclear accumulation.
INTRODUCTION
Circadian clocks, which drive daily cycles of behavior and physiology, are synchronized by cycles of light and temperature but drive persistent rhythms in the absence of any environmental inputs. The mechanism for these self-sustaining biological clocks has been subjected to genetic analyses in several model systems, including the fruit fly (Hardin, 2011) . While differences exist across the phylogenetic tree, a general feature of these clocks is regulation of transcription by proteins whose oscillations are controlled in part by posttranslational modifications. The Drosophila circadian clock has been a particularly useful model for the mammalian clock because most of the key circadian proteins are conserved in flies and mammals (Lowrey and Takahashi, 2011) . The Drosophila PERIOD protein (PER) is a key circadian transcriptional regulator conserved in flies and mammals, and its circadian oscillations have been extensively characterized at both the transcriptional and posttranscriptional levels. PER does not accumulate during the day because newly translated PER is phosphorylated by DOUBLETIME (DBT) and degraded, as is the TIMELESS protein (TIM), which is degraded in response to light via its interaction with the CRYPTOCHROME (CRY) photoreceptor. After the lights go out at night, the activity of DBT is antagonized by accumulating TIM, which also binds with PER and promotes its nuclear localization. In the nucleus, PER represses its transcription as well as the transcription of many other clock-controlled genes responsive to the CLOCK/ CYCLE (CLK/CYC) heterodimer. This repression is ultimately relieved when DBT targets PER for degradation after the lights return, thereby allowing another daily accumulation of PER (Hardin, 2011) .
DBT is an ortholog of vertebrate casein kinase Iε and d, which are likewise involved in the vertebrate circadian clock and target vertebrate PER orthologs for degradation (Lowrey and Takahashi, 2011) . Casein kinase Is (CKIs) are considered messenger-independent kinases that are not directly regulated by intracellular signaling, although prior phosphorylation upstream of a CKI target site can prime phosphorylation at that CKI target site, thereby linking CKI activity to intracellular signals (Gross and Anderson, 1998) . Likewise, priming of DBT activity by the NEMO kinase has been documented for its phosphorylation of PER (Chiu et al., 2011; Yu et al., 2011) .
Another potential mode of regulation for DBT may be conferred by proteins associating with DBT in multiprotein complexes to target or modulate its activity toward substrates. Genetic analyses may have missed some of these, because lack of DBT activity is lethal Price et al., 1998; Suri et al., 2000; Zilian et al., 1999) . In order to identify novel clock components that interact with DBT, and because recent proteomic analyses of the mammalian clock have identified several important components (Brown et al., 2005; Robles et al., 2010) , we undertook a proteomic analysis in Drosophila S2 cells to identify proteins that interact with DBT. Several proteins were identified in immunoprecipitates of MYC-tagged DBT, but not in control immunoprecipitates of cells lacking the tagged DBT; one of these proteins was the Drosophila ortholog of RACK1, which was also identified by Robles et al. (2010) as a component of mammalian clock protein complexes. The investigation of another one of these interactors is presented here. This protein interacts with DBT in vitro, in S2 cells, and in fly heads, and it is essential for normal cycles of PER nuclear accumulation and circadian behavior. Genetic analysis in flies and cell biological analysis in Drosophila S2 cells demonstrate that it stimulates DBT's clock functions, including phosphorylationdependent degradation of PER. Immunofluorescent analysis indicates that this DBT-interacting protein accumulates rhythmically in cytosolic foci at times when PER begins to accumulate in the nuclei of circadian cells. Furthermore, structural analysis demonstrates that this interactor is a noncanonical FK506-binding protein, thus highlighting a hitherto uncharacterized role for this class of proteins in the circadian clock.
RESULTS

Drosophila
Bride of DBT Interacts with DBT DBT proteins from S2 cells stably transformed with plasmid expressing MYC-tagged DBT proteins were immunoprecipitated with an anti-MYC resin, and coimmunoprecipitating proteins were visualized by SDS-PAGE. One protein immunoprecipitated with full-length DBT WT or catalytically inactive DBT K/R , but not with C-terminally truncated forms of DBT, and it was identified by mass spectrometry to be CG17282 (Table S1 available  online) . CG17282 is a previously unstudied predicted gene in the Drosophila genome sequence. Several approaches were employed to confirm the interaction with DBT. Using glutathione S-transferase (GST)-fused DBT, we are able to pull down in vitro-translated CG17282 ( Figure 1A ). Moreover, CG17282 was also shown to bind with DBT-MYC expressed from a transgene in S2 cells by coimmunoprecipitation ( Figure 1B) . DBT-MYC expressed in fly heads with the circadian driver timGAL4 coimmunoprecipitated with CG17282 ( Figure 1C ). Finally, as will be explained below, we were intrigued by the apparent lack of known functional domains in the N-terminal region of CG17282 and decided to test whether this region could mediate direct interaction with DBT. Because S2 cells express low levels of CG17282 and DBT, which could complicate interpretation of the binding data, we conducted pull-down experiments in HEK293 cells and found that DBT bound to the N-terminal region of CG17282 ( Figure 1D ).
In order to determine whether CG17282 binds directly to PER, in vitro-translated PER was incubated with GST-CG17282, and no interaction with PER was detected by GST pull-down (Figure S1 ). Therefore, it is unlikely that CG17282 binds PER directly. Because it encodes a DBT-binding protein, we have named this gene bride of dbt (bdbt), with a nod to a previous gene discovered as an interactor (Reinke and Zipursky, 1988) These results are representative of those obtained in three replicates. (A) GST pull-down assay. In vitro-translated CG17282 was incubated with glutathione beads bound with GST or a wild-type DBT-GST fusion protein (''dbt WT ''). In the upper panel, Coomassie staining detects GST proteins on the beads and ovalbumin (''OVA'') added to prevent nonspecific binding. In the lower panel, input or bound CG17282 (labeled with fluorescent lysine) is detected by laser scanning. (B) Coimmunoprecipitation assays of S2 cell extracts. Untagged DBT or DBT-MYC was expressed from a pMT plasmid in S2 cells, and the extracts were immunoprecipitated with an anti-MYC antibody. CG17282 was detected with antibodies to CG17282, while DBT-MYC was detected with an antibody to the C terminus of DBT and tubulin with an anti-tubulin antibody. (C) Coimmunoprecipitation of fly head extracts. DBT-MYC was expressed in transgenic flies (dbtmyc) with the genotype timGAL4 > UAS-dbt-myc, while control flies (nontransgenic, or NON-TF) contained only the timGAL4 driver. DBT-MYC was immunoprecipitated with antibodies to MYC from extracts collected at ZT1 and was detected in the immunoprecipitate with an antibody against DBT, while coimmunoprecipitated CG17282 was detected with antibody to CG17282. (D) Affinity isolation of CG17282(1-120) using GST-DBT. The N-terminal region of CG17282 with or without the coexpression of DBT-GST was transiently expressed in HEK293 cells and purified from cell lysates using glutathione beads. The presence of GST-DBT and CG17282 was detected by immunoblotting using antibodies raised against DBT and CG17282, respectively. See Table S1 for peptides from CG17282 identified in pull-downs with DBT-MYC and Figure S1 for the assay of PER/BDBT interaction.
Bride of DBT Expression in Circadian Cells Is Essential for Circadian Rhythms of Behavior
We employed several genetic approaches to assess whether Bride of DBT (BDBT) has a role in the mechanism of circadian rhythms. Overexpression of the FLAG-tagged BDBT in clock cells of flies (timGAL4 > UAS-bdbt-flag) did not produce an effect on their locomotor activity rhythms or PER/DBT expression (Table S2; Figures S2, S3A , and S3B). However, overexpression of DBT in circadian tissues produces only a slight lengthening of the circadian period (Fan et al., 2009; Muskus et al., 2007; Sekine et al., 2008; Xu et al., 2005) , demonstrating that manipulations increasing DBT activity over wild-type levels do not necessarily affect period. Because there are no mutations in the endogenous gene to allow assessment of loss-of-function phenotypes, we used RNAi knockdown of the endogenous transcript to investigate bdbt function. Wild-type flies maintained in constant darkness exhibit persistent circadian rhythms of activity, with high levels of activity during the daylight hours in a previous light/ dark regimen and low levels of activity during the dark hours in the previous light/dark cycle. However, flies with the genotype timGAL4 > UAS-dcr2; UAS-bdbt RNAi or elavGAL4 > UASdcr2; UAS-bdbt RNAi exhibited arrhythmic locomotor activity if allowed to age for 7 days before initiation of the assay (Table 1 ; Figure 2A ).
In a timGAL4 > UAS-bdbt RNAi genotype without a UAS-dcr2 gene, we obtained a weaker but more clearly circadian phenotype exhibiting long periods instead of arrhythmicity ( Figure 2B ; Table 1 ). Finally, light:dark cycles (LD) drove diurnally cycling behavior that lacked anticipation of the dark-to-light and lightto-dark transitions in timGAL4 > UAS-dcr2; UAS-bdbt RNAi flies ( Figure 2C) ; cycles of behavior which lack anticipation of the lighting transitions are typical of circadian loss-of-function mutants. Interestingly, the evening peak of activity was largely missing ( Figure 2C ), and this also speaks to altered circadian function. The bdbt RNAi behavioral phenotypes, which include long period and arrhythmic activity in DD and lack of anticipation to lighting transitions in LD, establish bdbt as a true circadian gene.
The parameters for RNAi knockdown were investigated. If assayed immediately after eclosion from pupae, timGAL4 > UAS-dcr2; UAS-bdbt RNAi flies were mostly rhythmic with wild-type periods (data not shown), suggesting that expression of the RNAi from the timGAL4 driver does not reach high enough levels to become effective until the adult stage. The results were obtained with both of the RNAi lines obtained from the VDRC (Table 1 ). The efficacy of the knockdown, shown by immunoblot ( Figure 3A , bottom panel), demonstrated partial knockdown of BDBT protein levels; incomplete knockdown with the circadian driver is expected if BDBT is expressed in noncircadian tissues. Consistent with expression in noncircadian neurons, knockdown with the general neuronal driver elav-GAL4 is more complete ( Figure S4C ).
BDBT Contributes to Phosphorylation-Mediated
Degradation of PER and to Posttranslational Regulation of DBT Consistent with the locomotor activity arrhythmicity, there were effects on PER and DBT expression. High levels of PER with fast mobility on SDS-PAGE, shown in a previous study to arise from hypophosphorylated PER (Edery et al., 1994) , persisted throughout the day with a dampened oscillation of PER levels in timGAL4 > UAS-dcr2; UAS-bdbt RNAi flies ( Figure 3A , middle panel). By contrast, PER expression in wild-type flies (''WT'') varied more strongly, with the highest levels expressed at ZT19 (7 hr after the lights go out) and highly phosphorylated (slow-mobility) forms of PER found from ZT1-7 (1 to 7 hr after the lights come on) (Edery et al., 1994) . Because high levels of phosphorylation (Muskus et al., 2007) . Note the long-period phenotype of bdbt RNAi flies without dcr2. The average periodogram amplitudes for timGAL4 > /100028, timGAL4 > /100028; UAS-bdbt-flag, and timGAL4 > /100028; UAS-dbt WT -myc/+ rhythmic flies are 87%, 100%, and 78% of the average for control progeny without a timGAL4 driver. n, the total number of flies tested. a Differed significantly from all other genotypes without UAS-dcr2 in the analysis by Tukey HSD, with p < 0.003. A one-way ANOVA of all the rhythmic flies without UAS-dcr2 (the bottom half of the table) indicated a significant effect of genotype on circadian period (F 5,62 = 4, p < 0.0001). b Ten of 16 flies died during the locomotor assay.
Neuron FK506-Binding Protein: A Circadian Clock Component ultimately target PER for degradation (Grima et al., 2002; Ko et al., 2002; Muskus et al., 2007; Price et al., 1998) , the persistent levels of PER (particularly at ZT7) in the bdbt RNAi knockdown are likely the consequence of its reduced phosphorylation.
Intriguingly, there was also an effect on DBT electrophoretic mobility, as a slow mobility form of DBT was present in timGAL4 > Table 1 . (C) These panels are averaged activity plots from multiple flies of the wild-type (Canton S) and UASdcr2; timGAL4 > /bdbt RNAi genotypes under an LD cycle. Lights were on from ZT0-12 (open rectangle) and off from ZT12-24 (dark rectangles), and the evening peak is largely missing in the knockdown genotype, with anticipation of the lighting transitions missing for both morning and evening peaks. VDRC line 100028 was used for all bdbt RNAi records shown. See Figure S3 for the molecular rhythms with BDBT-FLAG overexpression in a wild-type background and as a rescue in bdbt RNAi flies.
UAS-dcr2; UAS-bdbt RNAi flies (Figure 3A, top panel) . In S2 cells, slowmobility forms of DBT are produced by autophosphorylation of DBT (Fan et al., 2009 ; J.-Y.F., unpublished data), suggesting that the interaction of BDBT and DBT is necessary to maintain DBT in an unphosphorylated state or to degrade phosphorylated DBT. In order to assess the possibility that BDBT knockdown enhances the accumulation of phosphorylated DBT, extracts from wild-type and timGAL4 > UAS-dcr2; UAS-bdbt RNAi flies were treated with lambda phosphatase. The electrophoretic mobility of the slow-mobility DBT isoform found in the bdbt RNAi knockdown flies was converted to a faster-migrating one, comparable to the mobility of DBT in wild-type controls, which did not exhibit a mobility shift with phosphatase treatment ( Figure 3B ). The phosphatase-dependent shift was partially antagonized by inhibitors of phosphatase. Hence, bdbt RNAi knockdown enhances the accumulation of phosphorylated DBT and may produce other posttranslational effects on DBT as well, because phosphatase treatment did not convert DBT to a form with homogeneous mobility as in wild-type flies ( Figure 3B ). Reduced activity of DBT toward PER, potentially resulting from autophosphorylation of DBT (as in mammalian CKId/ε; Gross and Anderson, 1998) , may produce the hypophosphorylation and high levels of PER. Any reduction in activity as a consequence of increased DBT phosphorylation would not be compensated by increased expression of DBT, as quantification of multiple blots, with DBT signal normalized to that of tubulin, indicated equivalent levels of DBT expression in wild-type and timGAL4 > UAS-dcr2; UAS-bdbt RNAi flies ( Figure 3C ). As for the locomotor activity phenotypes, these molecular correlates on PER and DBT were produced by both RNAi lines and took from 4 to 7 days after eclosion to become manifest ( Figures  S4A and S4B) .
The persistent and relatively underphosphorylated levels of PER in timGAL4 > UAS-dcr2; UAS-bdbt RNAi flies suggest that BDBT normally acts to enhance the DBT-dependent phosphorylation and degradation of PER. This was tested by coexpression of BDBT with PER and/or DBT in S2 cells. Overexpression of BDBT enhanced PER degradation in a well-established assay for DBT-dependent PER degradation (Ko et al., 2002; Muskus et al., 2007) (Figure 4B ), consistent with an enhancement of DBT's effects on PER by BDBT. Intriguingly, when coexpressed with DBT or PER alone, BDBT also reduced the levels of DBT or PER ( Figure 4A ). The effect on PER may be mediated by BDBT's effect on DBT, which is expressed endogenously in S2 cells and may show enhanced targeting of transgenic PER in the presence of BDBT. The relevance of the effect on DBT for the circadian mechanism is not clear, as DBT levels do not exhibit circadian oscillations (Kloss et al., 2001; Bao et al., 2001) and are not higher in timGAL4 > UAS-dcr2; UASbdbt RNAi flies than in controls ( Figure 3C ). Nevertheless, the enhanced effect of DBT on PER in S2 cells in the presence of higher BDBT levels is all the more compelling because it occurs in the presence of lower levels of DBT (i.e., lower levels of DBT with BDBT coexpression are more effective at targeting PER than higher levels of DBT without BDBT coexpression).
The bdbt RNAi Behavioral and Molecular Phenotypes Are Rescued by Overexpression of Wild-Type BDBT and Suppressed by Overexpression of Wild-Type DBT In order to determine whether the bdbt RNAi knockdown phenotypes were a consequence of specific effects on bdbt RNA and to assess the relevance of DBT to the phenotype, circadian behavior and PER oscillations were assayed in bdbt RNAi genotypes into which a UAS-bdbt-flag or UAS-dbt-myc transgene had also been introduced (a rescue or genetic interaction experiment, respectively). In timGAL4 > UAS-bdbtRNA-RNAi; UASbdbt-flag flies, behavior was rhythmic in constant darkness (A) Fly heads were collected at the indicated time points in a light:dark cycle (with lights on from ZT0-12 and off from ZT12-24) and analyzed with immunoblots for the indicated antigens. ''WT'' flies were UAS-dcr2; timGAL4 > /+; TM3/+ control flies, while bdbt RNAi flies were UAS-dcr2; timGAL4 > /UASbdbt RNAi (from VDRC line 100028). RNAi knockdown of BDBT produced a form of DBT with retarded electrophoretic mobility due to phosphorylation of DBT (''p-DBT''; see B), reduced levels of hyperphosphorylated PER (''hyper-PER''), and elevated levels of hypophosphorylated PER. Levels of BDBT protein were lower in the knockdown flies than in controls. These results are representative of those obtained in three replicates. See Figure S4 for assessment of bdbt phenotype with other drivers and responders. (B) Head extracts were prepared from wild-type (''WT'') flies and UAS-dcr2; timGAL4 > /bdbt RNAi flies at ZT7 and treated (+) or not treated (À) with lambda phosphatase or treated with lambda phosphatase in the presence of phosphatase inhibitor (i). Then, the extracts were subjected to immunoblot analysis for detection of DBT and tubulin. Phosphatase treatment converts the slow-mobility form of DBT to a form with the same mobility as that found in wild-type flies, although heterogeneity remains, and the inhibitor antagonizes the conversion. (C) The levels of DBT and tubulin were assessed in immunoblot analyses of four experiments with scans of the chemifluorescent signals. In each experiment, the DBT signal (sum of all bands, both phosphorylated and unphosphorylated) for each sample was normalized to the tubulin signal for each sample, and these values were further normalized to the DBT/tubulin signal on the same blot for wild-type flies collected at ZT1, which therefore was assigned a value of ''1.'' The averages of the normalized protein levels (±SEM) are plotted here as a function of ZT and genotype. A one-way ANOVA revealed no statistically significant effect of group on normalized protein amount (F 7,24 = 0.863, p = 0.55).
and exhibited an average period in the wild-type range (Table 1 and Figure 2B ), the PER electrophoretic mobility shift at ZT1 was restored and the amount of DBT with slow electrophoretic mobility was reduced ( Figure S3C ), demonstrating a BDBT-specific rescue of the mutant phenotype. In addition, overexpression of DBT WT -MYC suppressed the bdbt RNAi phenotype ( Figure 2B ), while overexpression of a catalytically inactive DBT K/R -MYC did not and in fact enhanced the mutant phenotype by contributing to shortened lifespan (10 of 16 flies died during the assay; Figure S2C ; Table 1 ). The rescue experiment (along with the other biochemical and cell biology experiments described herein) establish the specific involvement of BDBT in the circadian phenotypes, while the bdbt RNAi knockdown molecular phenotype (PER hypophosphorylation), the suppression of the bdbt RNAi phenotype by wild-type DBT overexpression, and the enhancement of DBT-dependent PER degradation by BDBT in S2 cells all strongly support the conclusion that BDBT enhances DBT's circadian kinase activity.
BDBT Inhibits PER Nuclear Accumulation during the Day in the Neurons that Produce Circadian Rhythms of Behavior The circadian oscillation of PER in the lateral neurons of the brain (Helfrich-Fö rster, 1995; Zerr et al., 1990) , which are sufficient for circadian locomotor activity rhythms in DD (Frisch et al., 1994) , was affected by bdbt RNAi knockdown. In wildtype flies, high levels of nuclear PER were detected only at ZT1 and not at ZT13 in these neurons, whose cytosol is marked by expression of the neuropeptide PDF ( Figures 5A, 5C , and 5D ). High levels of PER were detected in nuclei of the LN v and in the LN d at all times of day in timGAL4 > UAS-dcr2; UAS-bdbt RNAi flies ( Figures 5B-5D ). While the rhythms of PER are largely blunted in the timGAL4 > UAS-dcr2; bdbt RNAi flies, the levels of nuclear PER in the LNs are somewhat elevated at ZT7, suggesting a weak long-period rhythm that did not reach statistical significance as the wild-type rhythm did ( Figures 5C and 5D ). Knockdown of BDBT in timGAL4 > UAS-dcr2, UAS-bdbt RNAi flies did not eliminate the circadian oscillation of PER subcellular localization in photoreceptor cells of the eye (first demonstrated in wild-type flies by Siwicki et al., 1988) (Table S3) , most likely because the knockdown of BDBT is less complete in the eye than in the LNs (we still detect substantial BDBT protein in the eye in the timGAL4 > UAS-dcr2; UAS-bdbt RNAi flies; data not shown).
The Transcription of bdbt Is Independent of the Transcription of slimb, which Encodes a Part of the PER-Degradation Machinery The E3 ubiquitin ligase component SLIMB is essential for degradation of PER, and slimb mutants produce elevated levels of PER (Grima et al., 2002; Ko et al., 2002) . Because it is adjacent to bdbt in the Drosophila melanogaster genome, it was important to determine if bdbt might in fact be a part of the same transcription unit as slimb. For a number of reasons, this possibility can be excluded. First, inspection of other fly genomes in Flybase demonstrates that orthologous genes to bdbt are not found adjacent to slimb in distantly related Drosophila species (e.g., Drosophila virilis). Moreover, an antibody to the N-terminal part of BDBT detected a protein of correct molecular weight (MW) on western blots (MW 33 kDa; Figure 3A , lower panel), and the levels of this protein were decreased by RNAimediated knockdown ( Figures 3A and S4C ) and increased (with a mobility shift as a consequence of the FLAG tag) in timGAL4 > UAS-bdbt-flag flies (Figures S3A-S3C ). These results show that BDBT is not a domain within a larger SLIMB protein (59-69 kDa). Previous work has shown that knockdown of SLIMB produces a different phenotype, with high levels of PER in a heterogeneous phosphorylation state (Grima et al., 2002) . Therefore, bdbt encodes a distinct transcription unit from BDBT leads to lower levels of PER and DBT. (B) pAC-per-HA, pMT-dbt-myc, and pAC-bdbt-flag were transiently transfected into Drosophila S2 cells as indicated, and different levels of DBT-MYC were induced. BDBT-FLAG, PER, and b-tubulin were detected as above, while DBT was detected with anti-DBTC, which detects both endogenous DBT (migrating between DBT-MYC and BDBT) and DBT-MYC. BDBT enhances the targeting of PER for degradation by DBT. (C) bdbt RNAi knockdown in S2 cells. dsRNAi for bdbt was produced from a PCR fragment for bdbt by in vitro transcription, and the dsRNAi (+) or buffer (À) was added to S2 cells. After 24 hr, cell extracts were analyzed on immunoblots. DBT levels increase while BDBT levels decrease in the cells treated with dsRNAi. These results are representative of those obtained in three replicates.
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slimb, and the phenotypes produced in the timGAL4 > UASdcr2; UAS-bdbt RNAi flies do not arise from loss of SLIMB expression. Overall levels of BDBT protein (Figure 3 ) or of its mRNA ( Figure S3D ) did not oscillate in the heads of wild-type flies. Taken together, these observations indicate that BDBT is a factor contributing to the circadian oscillations of PER in vivo by enhancing the DBT-dependent phosphorylation and degradation of PER.
BDBT Localizes to Cytosolic Foci in Photoreceptor Cells in a Manner Requiring PER and DBT, and This Localization Occurs when PER Is Accumulating in Nuclei
An antibody to the first 238 amino acids of BDBT was produced to analyze the distribution of BDBT in photoreceptor cells, which are the principal source of PER expression in fly heads. Strikingly, BDBT is found in cytosolic foci in these cells and there was a dramatic change in the abundance and subcellular localization of these foci during the course of the day in wild-type flies (Figure 6 ). During the day (ZT1 and ZT7), detection was limited to the outer part of the retina and was not observed in all photoreceptors. In early night (ZT13), the foci became more numerous and broadly localized in the retina, and by ZT19 most photoreceptors expressed high levels of the foci in both the inner and outer parts of the retina. In per o or timGAL4 > UAS-dcr2; UASdbt RNAi fly eyes, the abundance of the foci remained relatively low and was restricted to the outer layers of the retina at all times of day, demonstrating that PER and DBT are necessary for the diurnal changes in BDBT foci. It is noteworthy that BDBT levels Table S3 for PER oscillations in photoreceptors of UAS-dcr2; timGAL4 > /UAS-bdbt RNAi flies.
do not oscillate in heads (Figure 3 ) and are not reduced in the heads of per o and timGAL4 > UAS-dcr2; UAS-dbt RNAi flies (Figure S5) , suggesting that the changes in foci over the course of the day and in the mutant genotypes are not the result of changes in BDBT levels. Moreover, the lack of foci at ZT1 and ZT7, when BDBT levels are as high as those at ZT13 and ZT19, suggests that the BDBT foci are not an inherent feature of BDBT immunofluorescent detection; instead, they are likely to reflect a circadian-clock-dependent change in subcellular localization for Figure S5 for an analysis of BDBT levels in the heads of the genotypes analyzed here.
BDBT. A caveat is that the relatively constant levels of BDBT expression detected by immunoblot may derive mostly from other sites within the brain, since immunoreactivity is detected in the brain as well as the eyes and does not oscillate in the brain (not shown).
Structural Analyses of BDBT Reveal that It Is Related to FK506-Binding Proteins with Tetratricopeptide Repeats but Lacks the Residues that Confer FK506-Binding and Catalytic Activity
Searches of the databases to identify known functional domains within the BDBT sequence did not pinpoint any known modules, BDBT (cyan) . Loop regions between strand b4 and helix a1 and between strands b5 to b6 where most of the catalytic residues are found in FKBP1A are colored red and indicated using black arrows. Please note that the structures of these loops are dramatically altered in BDBT. Movie S1 depicts a 360 view of this overlay.
(C) Structure-based alignment of BDBT with FKBP1A shows conservation of secondary structural elements and some residues, but not the residues that bind FK506 or rapamycin. Strictly conserved residues are shaded in black and similar residues are colored gray. The letters a and b indicate the positions of a helices and b strands, respectively. Residues highlighted in red in the FKBP1A sequence are found in the overlapping FK506/rapamycin-binding sites and the isomerase catalytic site. This alignment was constructed using DaliLite (Holm et al., 2008) .
(D) Overlay of the structures of amino acids 139-330 of FKBP51 (white) and BDBT(1-211) (cyan/magenta).
(legend continued on next page)
Neuron FK506-Binding Protein: A Circadian Clock Component save for a homology to tetratricopeptide repeats (TPRs) in the C-terminal part of BDBT. A single TPR comprises $34 amino acids forming a helix-turn-helix motif, and search algorithms identified three such structural elements in the C-terminal part of the protein. Domains composed of TPR motifs often mediate protein-protein interactions (Zeytuni and Zarivach, 2012) , so that the inclusion of such structural elements in BDBT, while suggesting a role in mediating protein-protein interaction, was not especially informative.
To shed light into the function of BDBT in the Drosophila circadian clock, we determined two crystal structures: one of its N-terminal region (amino acids 1-120) that includes the DBTbinding site ( Figure 1D ) and one of the first 211 amino acids. The structure of BDBT(1-120) was solved by multiwavelength anomalous diffraction using L-selenomethionine-labeled protein and refined to 1.9 Å limiting resolution (R cryst /R free = 26.1%/ 28.0%; Table S4; Figure S6 ). This structure was then used as a model to determine the crystal structure of BDBT(1-211) using molecular replacement; the final model was refined to 2.5 Å (R cryst /R free = 19.7%/22.8%, Table S4 ). Overall, BDBT(1-211) includes two distinct domains ( Figure 7A ). Its N terminus (amino acids 1-120) is structurally homologous to the peptidyl prolyl isomerase (PPIase) regions of FK506-binding proteins (FKBPs), despite low sequence homology (Kang et al., 2008) . The closest structural homolog of the PPIase domain was identified through DALI as the prototypical immunophilin FKBP1A. These two molecules superimpose with a root-mean-square deviation (rmsd) of 3.6 Å over 74 residues, though they share only 16% sequence identity ( Figures 7B and 7C ). Compared to FKBP1A, the N terminus of BDBT includes an additional strand (b1) and the differences between BDBT and FKBP1A reside primarily in the loops linking strands b3 and b4, strand b4 to helix a1, and strands b5 to b6 ( Figure 7B ; Movie S1). These regions include amino acid residues that make up the FK506 and rapamycin-binding sites, which overlap with the site of the isomerase activity. Overall, only 2 of the 13 residues involved in drug-binding or catalytic activity (Ikura and Ito, 2007) are conserved in BDBT ( Figure 7C) , and the extended loop between strands b3 and b4 occludes the potential binding pocket ( Figure 7B ). Taken together with our affinity isolation assays ( Figure 1D ), these observations suggest that the function of the PPIase domain in BDBT is not to catalyze the cis/trans-isomerization of proline residues, but rather to mediate binding to DBT. The C-terminal region of BDBT (amino acids 121-211) is entirely a-helical and includes one TPR composed of helices a2 and a3 ( Figure 7A) . A DALI search identified FKBP51 as the closest homolog for BDBT(1-211). In spite of their 18% amino acid sequence identity, the two molecules superimpose with an rmsd of 3.65 Å over 171 residues ( Figure 7D ) (Sinars et al., 2003) . FKBP51 is an immunophilin thought to be involved in steroid hormone receptor activity and includes a catalytically active PPIase domain followed by a catalytically deficient PPIase domain and a TPR domain. Overall, our work indicates that BDBT is structurally related to the immunophilin FKBP51 and that it shares a common domain organization consisting of PPIase-like and TPR domains with noncanonical immunophilins such as FKBP38 or FKBPL (Jascur et al., 2005; Kang et al., 2008) . These structural insights will help guide future investigations into the mechanistic aspects of BDBT function.
DISCUSSION
While FKBPs were originally identified as mediators of the immunosuppressive effects of FK506 on calcineurin (Liu et al., 1991) and rapamycin on the Target of Rapamycin (TOR) (Heitman et al., 1991) , subsequent work has suggested their involvement in a wide range of signaling processes, including ones involved in neurodegeneration and cancer. In many cases, their function derives from their catalysis of cis-trans conversions of peptide bonds involving prolines (Kang et al., 2008) . However, BDBT lacks the necessary catalytic residues, as do several other noncanonical FKBPs. One of these noncanonical FKBPs (FKBP38) has been proposed to interact with TOR to suppress its activity, while interactions between FKBP38 and the small GTP-binding protein RHEB relieve this repression and activate TOR (Bai et al., 2007) . Intriguingly, TOR and RHEB have recently been show to modulate the circadian clock of Drosophila (Zheng and Sehgal, 2010) .
However, FKBP proteins have also been implicated in regulation of nuclear localization and protein stability. For instance, the noncanonical FKBP-like protein (FKBPL) has been implicated in the nuclear import of steroid hormone receptors in complexes with HSP90 proteins (Robson and James, 2012) . An interesting possibility is that BDBT is involved in regulating the import of PER/DBT complexes to the nucleus, and that at least some of this regulation is negative, as PER exhibits increased nuclear accumulation in BDBT knockdown flies ( Figure 5 ). This hypothesis is consistent with our structural work, which uncovered a resemblance between BDBT and the HSP90-binding protein FKBP51. The HSP90-binding site in FKBP51 localizes to its TPR domain and all but one of the residues that account for HSP90 binding are conserved in BDBT in spite of the low sequence homology with BDBT ( Figure 7E ) (Wu et al., 2004) . Since the N-terminal, PPIase-like domain of BDBT binds to DBT in HEK293 cells ( Figure 1D ), it is possible that BDBT assembles a DBT/PER/HSP90 complex, with DBT bound to the PPIase-like domain, HSP90 to the TPR domain, and PER bound to DBT.
FKBPs have also been implicated in the regulation of the stabilities of proteins with which they form a complex (Kang et al., 2008) . A role in enhancement of PER's phosphorylation-dependent proteolysis is particularly attractive for BDBT, as it would explain the RNAi knockdown phenotype in head extracts (elevated levels of hypophosphorylated PER; Figure 3 ) and the enhancement of DBT-dependent degradation of PER in S2 cells (E) Sequence alignment of the TPR region of BDBT with the TPR and HSP90 binding regions of human FKBP51, FKBP52, and FKBPL. The numbering on the top refers to FKBP51. The secondary structures of FKBP51 and BDBT derived from their crystal structures are indicated above and below the sequence alignment, respectively. Strictly conserved residues are shaded in black and similar residues are colored gray. Amino acids that bind to HSP90 in FKBP51 are colored red (Wu et al., 2004) . See Table S4 for data collection and refinement statistics and Figure S6 for a summary of the structure determination procedure for BDBT(1-120) and BDBT(1-211). Figure 6 ) when PER transitions from a destabilized cytosolic form to a stabilized nuclear form, and our data supporting the involvement of BDBT in enhancement of PER proteolysis suggest that BDBT may be a negative regulator of this transition (i.e., BDBT antagonizes PER accumulation and nuclear localization). The BDBT foci are intriguing in light of the finding by Young and coworkers of PER/TIM cytosolic foci, which form prior to accumulation of PER and TIM in S2 cell nuclei (Meyer et al., 2006) . It was proposed that processes in these foci trigger the nuclear accumulation of both PER and TIM. Since the suggestion from our work is that BDBT foci antagonize nuclear accumulation of PER and we do not observe obvious PER foci that colocalize with the BDBT foci (Figure 6 ), it is possible that BDBT antagonizes focal accumulation of PER or immediately triggers the degradation of PER in these foci. In this scenario, in contrast to the situation in S2 cells, PER might only accumulate in foci in vivo when BDBT is not present or active in the foci, and PER's presence in foci in vivo may therefore be difficult to detect because it rapidly accumulates and localizes to nuclei when BDBT is not active in the foci. It is also possible that focal accumulation of BDBT negatively regulates BDBT activity toward DBT, since highest levels of BDBT foci are detected at ZT19, when PER is rapidly accumulating in nuclei ( Figure 6 ) and therefore any BDBT inhibition of PER nuclear accumulation might be inhibited.
Because the mammalian orthologs of DBT (CKIε and CKId) are also essential for the molecular mechanism of the mammalian circadian clock (Fan et al., 2009; Lee et al., 2001 Lee et al., , 2009 Lowrey et al., 2000; Xu et al., 2005) , it is possible that the mechanism in which bdbt participates is conserved in mammals. While this manuscript was in preparation, FKBP and FKBP-like proteins were reported to form complexes with mammalian CKId and CKIε (Kategaya et al., 2012) , although neither these proteins nor any other protein in the mammalian genome is an ortholog of BDBT. We were initially surprised by the lack of homology between the PPIase-like region in BDBT, which mediates binding to DBT ( Figure 1D ), and the ones found in vertebrates. However, our binding experiments indicate that the BDBT binding site in DBT spans its well-conserved N-terminal kinase domain and the poorly conserved C-terminal tail (not shown). Thus, it seems likely that the binding modes between BDBT and DBT on one hand and the ones between the vertebrate homologs of BDBT and CKId and CKIε differ substantially. While it is not known if this interaction has any role in the mammalian circadian clock, these results offer the tantalizing prospect that this class of proteins and their roles are conserved in the mechanisms of the mammalian and Drosophila clocks. Muskus et al., 2007) or DBT proteins truncated at various amino acids in the C-terminal domain, which is dispensable for catalytic activity (amino acids 387, 332, and 296) (Fan et al., 2009) , were immunoprecipitated with an anti-MYC resin, and coimmunoprecipitating proteins were visualized by SDS-PAGE. One protein immunoprecipitated with full-length DBT WT or DBT K/R , but not with C-terminally truncated forms of DBT. Excised Coomassie-stained gel bands were reduced and alkylated and subjected to in-gel trypsin digestion by standard methods, and extracted peptides were analyzed by capillary liquid chromatography-tandem mass spectrometry using a 50 mM i.d. 3 8-cm-long capillary column packed with Phenomenex Jupiter C18 reversed-phase matrix resolved with a linear gradient of acetonitrile as described previously (Keightley et al., 2004) . Protein identifications were made using Mascot 2.0 (Matrix Science) searching against MSDB compiled database release Jan 3, 2004 (1,319,480 sequences), with manual validation. All peptides used for identification and shown in Table S1 received ions scores exceeding threshold for 95% confidence (Perkins et al., 1999) . Peptides from CG17282 were also detected in two other experiments involving immunoprecipitation of DBT-MYC.
RNAi Fly Stocks and Locomotor Activity Assays UAS-cg17282 RNAi and UAS-dbt RNAi stocks were obtained from the Vienna Drosophila RNAi Center and the GAL4 driver lines from the Bloomington Stock Center. These lines, the genetic crosses employing them, and the activity assays are described in greater detail in Supplemental Experimental Procedures in Supplemental Information. UAS-dbt-myc lines have been previously described (Muskus et al., 2007) .
Generation of BDBT Expression Clones and Transgenic Flies
A cDNA clone for cg17282 (RE50353) was obtained from the Drosophila Genomics Resource Center (DGRC). In order to clone it into vectors allowing expression in Drosophila S2 cells or flies, the DGRC Gateway collection was employed. BDBT was cloned into pGateway vector pAWF (cat 1112) or pTWF (cat 1116), thereby generating a C-terminal 33 FLAG-tag and allowing constitutive expression from the Act5C promoter in S2 cells or flies (with a GAL4 driver), respectively. Transformants were produced by Genetic Services. More complete descriptions are given in Supplemental Experimental Procedures.
Transfection of Drosophila S2 Cells S2 cells were transiently transfected with pAC-bdbt-flag, pMT-dbt-myc, and/ or pAC-per-ha by cellfectin II (Life Technologies) treatment as previously described (Muskus et al., 2007) or were treated with double-stranded RNAi (dsRNAi) for BDBT. To make the dsRNAi, a PCR product was amplified from BDBT clone RE50353 with Bull's eye Taq polymerase (Midwest Scientific) and primers that introduced T7 promoters on each end of the product (forward primer: 5 0 -GTAATACGACTCACTATAGGG-3 0 ; reverse primer: 5 0 -TTAATAC GACTCACTATAGGGAGAACTAAACATACGTTGCACCA). Then, T7 RNA polymerase (Megascript RNAi kit, cat AM1626; Life Technologies) was used to produce dsRNAi, and this was applied to S2 cells according to the procedure of the Perrimon lab (http://www.flyrnai.org/DRSC-PRR.html).
BDBT/DBT Interaction Assays
These included GST pull-down assays and immunoprecipitations from Drosophila S2 cells, fly heads, and human embryonic kidney cells, as described in Supplemental Experimental Procedures.
Immunodetection of DBT, PER, and BDBT Antibodies to BDBT were generated to the first 120 or to the first 238 amino acids of BDBT expressed in E. coli and purified as described in Supplemental Experimental Procedures. The antibodies were generated in guinea pig by Covance Research Products. For immunoblot assays, crude extracts or immunoprecipitates were subjected to SDS-PAGE, transferred to nitrocellulose, and antigens detected with the appropriate antibodies as described in Supplemental Experimental Procedures. Extracts were analyzed on either 5.7% (for PER) or 10% (for DBT, tubulin, actin, and BDBT) SDS-PAGE gels with the ECL procedure (GE Healthcare) (Muskus et al., 2007) . Typically, immunoblots of independent experiments were performed three times for each figure (see figure legends) .
For analysis of DBT modification in bdbt RNAi flies, head extracts were prepared at ZT7 by sonication in 13 phosphatase buffer (7 ml per head in 1.13 buffer from New England Biolabs) and centrifugation at 10,000 rpm for 10 min in a microfuge, and the supernatant was aliquotted into 6 ml aliquots for treatment with 1 ml of lambda phosphatase (400 U) in 20 ml for 2 hr at 30 C, with no enzyme or enzyme with phosphatase inhibitors (10 mM Na Vanadate and 50 mM NaFl). Then, 53 SDS loading buffer was added, the samples were treated for 5 min at 100 C, and half the sample was loaded on an SDS 10% polyacrylamide gel for immunoblot analysis as described above. For immunodetection in whole adult brains, brains were dissected from flies at ZT1, ZT7, ZT13, or ZT19; fixed, permeabilized, and incubated with rabbit anti-PER and mouse anti-PDF; and followed by incubation with fluorescently labeled secondary antibodies (anti-rabbit immunoglobulin G [IgG] Alexa Fluor 488 and anti-mouse IgG Alexa Fluor 568, respectively) and imaging on an Olympus Fluoview confocal. For detection of PER or BDBT in the eyes, sections prepared with a cryostat were processed for immunocytochemical detection of PER and DIC imaging or for fluorescent detection of PER (detected with rabbit anti-PER and anti-rabbit IgG Alexa Fluor 568) and BDBT (detected with guinea pig anti-BDBT[1-238] and anti-guinea pig IgG Alexa Fluor 488). Images were scored as described in the figure legends. More details are given in Supplemental Experimental Procedures.
Quantitative RT-PCR Analysis A total of 90-100 fly heads were collected and quick-frozen in liquid nitrogen, and total RNAs were then extracted with an RNA isolation kit (QIAGEN). After quantification of the total RNA, each sample was treated with DNase I for 15 min at room temperature and analyzed for rp49, per, and bdbt levels by quantitative real-time RT-PCR, as described in Supplemental Experimental Procedures.
Protein Purification and Crystal Structure Determination
See Supplemental Experimental Procedures for descriptions of protein expression, purification, and crystal structure determination.
ACCESSION NUMBERS
Coordinates and structure factors for BDBT(1-120) and BDBT(1-211) have been deposited in the Protein Data Bank with accession numbers 4IT6 and 4IT4, respectively.
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